ALISON ALLOR: Open Payments
NPI 1184811036 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$887 in 39 payments from 16 companies in 2025. Trend: 2023 $7,051 · 2024 $9,453 · 2025 $887
Food & beverage: $852Education: $36
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $258 |
| AstraZeneca Pharmaceuticals LP | 5 | $100 |
| Novo Nordisk Inc | 3 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Ardelyx, Inc. | 3 | $57 |
| OPKO Pharmaceuticals, LLC | 2 | $36 |
| Alexion Pharmaceuticals, Inc. | 1 | $31 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
Products named: Vanrafia, Fabhalta, FARXIGA, Wegovy, JARDIANCE, Kerendia, JYNARQUE, IBSRELA.
Industry payments across MI — which companies pay providers there.
